Status:
RECRUITING
Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use Disorder
Bloodstream Infection
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This project is a pilot study of an adapted intervention of an existing Opioid Use Disorder (OUD) treatment retention intervention called Recovery Management Checkups (RMC). This intervention has been...
Eligibility Criteria
Inclusion
- Between 18 and 65 years of age
- Able to provide Informed Consent
- Admitted to Boston Medical Center on any inpatient unit for an active serious injection related infection (SIRI) such as endocarditis, osteomyelitis, bacteremia, septic arthritis, epidural abscess or other serious infection in which two weeks or more of antibiotics are recommended
Exclusion
- Not able to give informed consent
- Cognitive ability (defined through Research Assistant (RA) determination)
- Inability to complete assessments in English or Spanish (defined through RA determination).
- Exclusion for any reason under PI discretion
- Unable to provide names and contact information for at least two verifiable locator persons who will know where to find them in the future.
- In police custody or expecting incarceration
Key Trial Info
Start Date :
January 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06489535
Start Date
January 6 2025
End Date
March 1 2026
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118